C222H270Br2Cl6F12N38O24 — CID 161196892
bis(N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3-hydroxy-3-methylbutanamide);bis(N-(6-chloro-7-cyano-1-cyclobutylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide);N-(4-chloro-1-cyclobutyl-6-cyclopropylbenzimidazol-2-yl)-3-(fluoromethyl)-3-hydroxypentanamide;tris(N-(4-chloro-1-cyclobutyl-6-cyclopropylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide);N-(1-cyclobutyl-6-cyclopropyl-4-fluorobenzimidazol-2-yl)-3-(fluoromethyl)-3-hydroxypentanamide;tris(N-(1-cyclobutyl-6-cyclopropyl-4-fluorobenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide) (PubChem CID 161196892) has the molecular formula C222H270Br2Cl6F12N38O24 and a molecular weight of 4455.35 g/mol. Its IUPAC name is bis(N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3-hydroxy-3-methylbutanamide);bis(N-(6-chloro-7-cyano-1-cyclobutylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide);N-(4-chloro-1-cyclobutyl-6-cyclopropylbenzimidazol-2-yl)-3-(fluoromethyl)-3-hydroxypentanamide;tris(N-(4-chloro-1-cyclobutyl-6-cyclopropylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide);N-(1-cyclobutyl-6-cyclopropyl-4-fluorobenzimidazol-2-yl)-3-(fluoromethyl)-3-hydroxypentanamide;tris(N-(1-cyclobutyl-6-cyclopropyl-4-fluorobenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide).
| Compound Name | bis(N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3-hydroxy-3-methylbutanamide);bis(N-(6-chloro-7-cyano-1-cyclobutylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide);N-(4-chloro-1-cyclobutyl-6-cyclopropylbenzimidazol-2-yl)-3-(fluoromethyl)-3-hydroxypentanamide;tris(N-(4-chloro-1-cyclobutyl-6-cyclopropylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide);N-(1-cyclobutyl-6-cyclopropyl-4-fluorobenzimidazol-2-yl)-3-(fluoromethyl)-3-hydroxypentanamide;tris(N-(1-cyclobutyl-6-cyclopropyl-4-fluorobenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide) |
|---|---|
| PubChem CID | 161196892 |
| Molecular Formula | C222H270Br2Cl6F12N38O24 |
| Molecular Weight | 4455.35 g/mol |
| Exact Mass | 4447.74 |
| IUPAC Name | bis(N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3-hydroxy-3-methylbutanamide);bis(N-(6-chloro-7-cyano-1-cyclobutylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide);N-(4-chloro-1-cyclobutyl-6-cyclopropylbenzimidazol-2-yl)-3-(fluoromethyl)-3-hydroxypentanamide;tris(N-(4-chloro-1-cyclobutyl-6-cyclopropylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide);N-(1-cyclobutyl-6-cyclopropyl-4-fluorobenzimidazol-2-yl)-3-(fluoromethyl)-3-hydroxypentanamide;tris(N-(1-cyclobutyl-6-cyclopropyl-4-fluorobenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide) |
| SMILES | CC(C)(O)CC(=O)Nc1nc2c(C(F)(F)F)cc(Br)cc2n1C1CCC1.CC(C)(O)CC(=O)Nc1nc2c(C(F)(F)F)cc(Br)cc2n1C1CCC1.CC(C)(O)CC(=O)Nc1nc2c(Cl)cc(C3CC3)cc2n1C1CCC1.CC(C)(O)CC(=O)Nc1nc2c(Cl)cc(C3CC3)cc2n1C1CCC1.CC(C)(O)CC(=O)Nc1nc2c(Cl)cc(C3CC3)cc2n1C1CCC1.CC(C)(O)CC(=O)Nc1nc2c(F)cc(C3CC3)cc2n1C1CCC1.CC(C)(O)CC(=O)Nc1nc2c(F)cc(C3CC3)cc2n1C1CCC1.CC(C)(O)CC(=O)Nc1nc2c(F)cc(C3CC3)cc2n1C1CCC1.CC(C)(O)CC(=O)Nc1nc2ccc(Cl)c(C#N)c2n1C1CCC1.CC(C)(O)CC(=O)Nc1nc2ccc(Cl)c(C#N)c2n1C1CCC1.CCC(O)(CF)CC(=O)Nc1nc2c(Cl)cc(C3CC3)cc2n1C1CCC1.CCC(O)(CF)CC(=O)Nc1nc2c(F)cc(C3CC3)cc2n1C1CCC1 |
| InChI | InChI=1S/C20H25ClFN3O2.C20H25F2N3O2.3C19H24ClN3O2.3C19H24FN3O2.2C17H19BrF3N3O2.2C17H19ClN4O2/c1-2-20(27,11-22)10-17(26)23-19-24-18-15(21)8-13(12-6-7-12)9-16(18)25(19)14-4-3-5-14;1-2-20(27,11-21)10-17(26)23-19-24-18-15(22)8-13(12-6-7-12)9-16(18)25(19)14-4-3-5-14;6*1-19(2,25)10-16(24)21-18-22-17-14(20)8-12(11-6-7-11)9-15(17)23(18)13-4-3-5-13;2*1-16(2,26)8-13(25)22-15-23-14-11(17(19,20)21)6-9(18)7-12(14)24(15)10-4-3-5-10;2*1-17(2,24)8-14(23)21-16-20-13-7-6-12(18)11(9-19)15(13)22(16)10-4-3-5-10/h2*8-9,12,14,27H,2-7,10-11H2,1H3,(H,23,24,26);6*8-9,11,13,25H,3-7,10H2,1-2H3,(H,21,22,24);2*6-7,10,26H,3-5,8H2,1-2H3,(H,22,23,25);2*6-7,10,24H,3-5,8H2,1-2H3,(H,20,21,23) |
| InChIKey | UULRKCIVKAJCLQ-UHFFFAOYSA-N |
| XLogP | 49.81 |
| TPSA | 853.38 Ų |
| H-Bond Donors | 24 |
| H-Bond Acceptors | 50 |
| Rotatable Bonds | 60 |
| Heavy Atoms | 304 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4455.35 |
| LogP ≤ 5 | 49.81 |
| H-Bond Donors ≤ 5 | 24 |
| H-Bond Acceptors ≤ 10 | 50 |